The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Sprouts Farmers Market, Inc.’s SFM shares have demonstrated momentum on the bourses. Closing at $166.13 yesterday, shares are ...

Roche (RHHBY) announced that the Food and Drug Administration has approved a New Drug Application for an Evrysdi tablet for people living with ...

Infants with SMA type 1 born since 2016 experience better functional outcomes and life expectancy with disease-modifying treatments.

A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

The Strata Management Act 2013 (SMA 2013) came into force in most of the states within Peninsular Malaysia on June 1, 2015. What is also significant is that it sought to provide a uniform share unit ...

The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

The tablet formulation can either be swallowed whole or dispersed in a teaspoon of filtered (non-chlorinated) water.

The media company plans to unveil six ETF and SMA products focusing on American manufacturing, energy, and crypto investments ...

Senate Bill 1296 would not require special management area permits for structures in Lahaina town if they were destroyed in ...